One report has described HHV-6 reactivation in the central nervous system of a COVID-19 patient with HHV-6 myelitis and concomitant myelin oligodendrocyte glycoprotein antibody-mediated parainfectious myelitis. This evidence concerns the gene OMG and COVID-19.